Arbutus Biopharma (ABUS) PT Lowered to $6 at H.C. Wainwright
Tweet
Share
E-mailGet Alerts ABUS Hot Sheet
Price: $4.67 +1.97%
Rating Summary:
7 Buy, 2 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Rating Summary:
7 Buy, 2 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Join SI Premium – FREE
H.C. Wainwright analyst Ed Arce lowered the price target on Arbutus Biopharma (NASDAQ: ABUS) to $6.00 (from $7.50) while maintaining a Buy rating.
You May Also Be Interested In
- Arbutus Reports Second Quarter 2026 Financial Results and Provides Corporate Update
- LG Electronics India (LGEL:IN) PT Raised to INR1,815 at ICICI Securities
- KP Tissue Inc. (KPT:CN) (KPTSF) PT Raised to Cdn$13.50 at Desjardins
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
